Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Electroencephalography | 147 | 2024 | 6240 | 13.920 |
Why?
|
Seizures | 52 | 2024 | 2964 | 7.600 |
Why?
|
Coma | 19 | 2023 | 484 | 5.310 |
Why?
|
Epilepsy | 38 | 2024 | 3303 | 4.900 |
Why?
|
Brain Waves | 13 | 2023 | 409 | 3.320 |
Why?
|
Subarachnoid Hemorrhage | 15 | 2024 | 1033 | 3.250 |
Why?
|
Heart Arrest | 10 | 2023 | 1513 | 2.760 |
Why?
|
Delirium | 14 | 2024 | 1667 | 2.680 |
Why?
|
Signal Processing, Computer-Assisted | 10 | 2024 | 1493 | 2.640 |
Why?
|
Anticonvulsants | 14 | 2024 | 1910 | 2.530 |
Why?
|
Status Epilepticus | 14 | 2021 | 461 | 2.530 |
Why?
|
Sleep | 24 | 2024 | 4764 | 2.350 |
Why?
|
Sleep Stages | 13 | 2024 | 695 | 2.140 |
Why?
|
Intensive Care Units | 26 | 2023 | 3743 | 2.100 |
Why?
|
Polysomnography | 18 | 2024 | 1852 | 2.000 |
Why?
|
Sleep Apnea, Obstructive | 12 | 2023 | 1877 | 1.900 |
Why?
|
Critical Illness | 15 | 2023 | 2709 | 1.890 |
Why?
|
Models, Neurological | 8 | 2021 | 1768 | 1.680 |
Why?
|
Brain Ischemia | 13 | 2022 | 3030 | 1.630 |
Why?
|
Brain | 37 | 2024 | 27100 | 1.600 |
Why?
|
Propofol | 8 | 2024 | 602 | 1.600 |
Why?
|
Epilepsy, Generalized | 3 | 2024 | 178 | 1.590 |
Why?
|
Sleep Apnea Syndromes | 6 | 2022 | 978 | 1.560 |
Why?
|
Critical Care | 16 | 2022 | 2691 | 1.510 |
Why?
|
Algorithms | 32 | 2024 | 14024 | 1.510 |
Why?
|
Brain Injuries | 11 | 2024 | 2053 | 1.460 |
Why?
|
Monitoring, Physiologic | 15 | 2023 | 1780 | 1.420 |
Why?
|
Decision Support Techniques | 13 | 2021 | 1999 | 1.420 |
Why?
|
Brain Diseases | 5 | 2021 | 1546 | 1.400 |
Why?
|
Hepatic Encephalopathy | 3 | 2024 | 143 | 1.380 |
Why?
|
Dementia | 7 | 2024 | 2686 | 1.250 |
Why?
|
Neurotoxicity Syndromes | 2 | 2022 | 301 | 1.250 |
Why?
|
Hypoxia-Ischemia, Brain | 5 | 2020 | 353 | 1.200 |
Why?
|
Humans | 251 | 2024 | 760740 | 1.160 |
Why?
|
Benzodiazepines | 3 | 2024 | 1133 | 1.020 |
Why?
|
Epilepsy, Temporal Lobe | 4 | 2022 | 390 | 1.010 |
Why?
|
Heart Rate | 5 | 2019 | 4181 | 0.990 |
Why?
|
Respiration, Artificial | 7 | 2022 | 2630 | 0.930 |
Why?
|
Anesthetics | 3 | 2020 | 523 | 0.920 |
Why?
|
Cerebral Infarction | 4 | 2021 | 980 | 0.920 |
Why?
|
Automation | 5 | 2024 | 585 | 0.890 |
Why?
|
Natural Language Processing | 5 | 2024 | 1166 | 0.890 |
Why?
|
Hypnotics and Sedatives | 6 | 2023 | 1178 | 0.880 |
Why?
|
Glasgow Outcome Scale | 3 | 2018 | 104 | 0.850 |
Why?
|
Retrospective Studies | 56 | 2024 | 80583 | 0.830 |
Why?
|
Adult | 89 | 2024 | 220995 | 0.830 |
Why?
|
Epilepsy, Post-Traumatic | 2 | 2022 | 40 | 0.800 |
Why?
|
Middle Aged | 85 | 2024 | 220603 | 0.800 |
Why?
|
Anesthetics, Intravenous | 4 | 2018 | 394 | 0.780 |
Why?
|
Artificial Intelligence | 6 | 2024 | 2575 | 0.780 |
Why?
|
Conscious Sedation | 2 | 2016 | 532 | 0.780 |
Why?
|
Self Report | 5 | 2024 | 3727 | 0.750 |
Why?
|
Catatonia | 1 | 2024 | 178 | 0.750 |
Why?
|
Aged | 77 | 2024 | 169092 | 0.740 |
Why?
|
Electronic Health Records | 9 | 2024 | 4810 | 0.740 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2022 | 1462 | 0.730 |
Why?
|
Male | 113 | 2024 | 360402 | 0.730 |
Why?
|
Female | 116 | 2024 | 392203 | 0.710 |
Why?
|
Anesthesia, Intravenous | 2 | 2018 | 129 | 0.710 |
Why?
|
Alzheimer Disease | 6 | 2024 | 8603 | 0.700 |
Why?
|
Continuous Positive Airway Pressure | 3 | 2021 | 574 | 0.700 |
Why?
|
Software | 7 | 2023 | 4432 | 0.670 |
Why?
|
Confusion | 1 | 2022 | 278 | 0.670 |
Why?
|
Severity of Illness Index | 10 | 2024 | 15829 | 0.660 |
Why?
|
Forecasting | 4 | 2024 | 2924 | 0.650 |
Why?
|
Electrocardiography | 6 | 2020 | 6346 | 0.640 |
Why?
|
Neurology | 2 | 2024 | 784 | 0.640 |
Why?
|
Aging | 6 | 2024 | 8700 | 0.610 |
Why?
|
Sensitivity and Specificity | 18 | 2021 | 14649 | 0.600 |
Why?
|
Prospective Studies | 27 | 2024 | 54364 | 0.570 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2018 | 246 | 0.560 |
Why?
|
Airway Obstruction | 1 | 2022 | 661 | 0.560 |
Why?
|
Computer Simulation | 8 | 2024 | 6233 | 0.560 |
Why?
|
Cerebral Cortex | 6 | 2021 | 5776 | 0.560 |
Why?
|
Reproducibility of Results | 18 | 2024 | 20077 | 0.560 |
Why?
|
Ventilator-Induced Lung Injury | 1 | 2018 | 120 | 0.560 |
Why?
|
Deep Sedation | 1 | 2018 | 118 | 0.550 |
Why?
|
Hypothermia, Induced | 4 | 2017 | 754 | 0.540 |
Why?
|
Consciousness | 3 | 2019 | 600 | 0.530 |
Why?
|
Models, Theoretical | 6 | 2021 | 3567 | 0.520 |
Why?
|
Diagnosis | 2 | 2014 | 156 | 0.520 |
Why?
|
Sentinel Surveillance | 1 | 2018 | 291 | 0.520 |
Why?
|
Anesthetics, Inhalation | 5 | 2020 | 572 | 0.520 |
Why?
|
Ventilators, Mechanical | 1 | 2018 | 288 | 0.520 |
Why?
|
Education, Distance | 1 | 2019 | 259 | 0.510 |
Why?
|
Early Diagnosis | 3 | 2020 | 1185 | 0.510 |
Why?
|
ROC Curve | 9 | 2021 | 3575 | 0.510 |
Why?
|
Information Theory | 1 | 2014 | 49 | 0.450 |
Why?
|
Psychomotor Agitation | 1 | 2016 | 305 | 0.450 |
Why?
|
Chorea | 1 | 2014 | 79 | 0.450 |
Why?
|
Probability | 5 | 2018 | 2475 | 0.450 |
Why?
|
Life Expectancy | 2 | 2021 | 1242 | 0.440 |
Why?
|
Periodicity | 4 | 2021 | 347 | 0.440 |
Why?
|
Prognosis | 16 | 2022 | 29601 | 0.440 |
Why?
|
Nonlinear Dynamics | 1 | 2016 | 491 | 0.440 |
Why?
|
Inpatients | 3 | 2023 | 2545 | 0.430 |
Why?
|
Cerebrospinal Fluid Shunts | 1 | 2014 | 195 | 0.420 |
Why?
|
Patient Discharge | 3 | 2023 | 3442 | 0.420 |
Why?
|
Vagus Nerve Stimulation | 1 | 2016 | 229 | 0.410 |
Why?
|
Immunotherapy, Adoptive | 2 | 2022 | 1467 | 0.410 |
Why?
|
Respiration | 2 | 2020 | 1656 | 0.400 |
Why?
|
Epidemiologic Methods | 1 | 2017 | 1335 | 0.400 |
Why?
|
Basal Ganglia Hemorrhage | 1 | 2011 | 8 | 0.390 |
Why?
|
Circadian Rhythm | 1 | 2023 | 2569 | 0.380 |
Why?
|
Cost-Benefit Analysis | 5 | 2021 | 5493 | 0.380 |
Why?
|
Cost of Illness | 1 | 2021 | 1937 | 0.380 |
Why?
|
Efficiency | 1 | 2014 | 476 | 0.370 |
Why?
|
Brain Infarction | 1 | 2013 | 289 | 0.370 |
Why?
|
Hematologic Neoplasms | 1 | 2022 | 1896 | 0.360 |
Why?
|
Secondary Prevention | 3 | 2021 | 1470 | 0.360 |
Why?
|
Polycythemia | 1 | 2011 | 124 | 0.360 |
Why?
|
Preventive Medicine | 1 | 2012 | 245 | 0.360 |
Why?
|
Dexmedetomidine | 3 | 2023 | 317 | 0.350 |
Why?
|
Movement Disorders | 1 | 2014 | 459 | 0.350 |
Why?
|
Aged, 80 and over | 27 | 2021 | 58919 | 0.350 |
Why?
|
Databases, Factual | 6 | 2020 | 7963 | 0.340 |
Why?
|
Intracranial Aneurysm | 2 | 2018 | 1285 | 0.340 |
Why?
|
Neurophysiology | 2 | 2023 | 144 | 0.340 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2017 | 846 | 0.340 |
Why?
|
Research Design | 5 | 2024 | 6174 | 0.340 |
Why?
|
Markov Chains | 6 | 2018 | 965 | 0.340 |
Why?
|
Treatment Outcome | 16 | 2024 | 64572 | 0.340 |
Why?
|
Young Adult | 26 | 2024 | 59191 | 0.330 |
Why?
|
Cross Infection | 2 | 2018 | 1422 | 0.330 |
Why?
|
Cohort Studies | 18 | 2024 | 41464 | 0.330 |
Why?
|
Metabolome | 1 | 2016 | 988 | 0.320 |
Why?
|
Predictive Value of Tests | 12 | 2021 | 15250 | 0.320 |
Why?
|
Decision Trees | 4 | 2020 | 504 | 0.310 |
Why?
|
Accidents, Traffic | 1 | 2014 | 816 | 0.310 |
Why?
|
Brain Mapping | 5 | 2020 | 6635 | 0.310 |
Why?
|
Monitoring, Intraoperative | 1 | 2015 | 941 | 0.300 |
Why?
|
Physicians | 2 | 2020 | 4583 | 0.300 |
Why?
|
Anesthesia | 3 | 2017 | 1591 | 0.300 |
Why?
|
Stroke | 8 | 2024 | 9715 | 0.300 |
Why?
|
Time Factors | 16 | 2020 | 39908 | 0.300 |
Why?
|
Risk Assessment | 9 | 2021 | 23974 | 0.290 |
Why?
|
Observer Variation | 5 | 2020 | 2607 | 0.290 |
Why?
|
Memory Disorders | 1 | 2014 | 1197 | 0.280 |
Why?
|
Epilepsies, Partial | 3 | 2021 | 431 | 0.280 |
Why?
|
Out-of-Hospital Cardiac Arrest | 2 | 2022 | 339 | 0.270 |
Why?
|
Internship and Residency | 2 | 2024 | 5878 | 0.270 |
Why?
|
Academic Medical Centers | 4 | 2022 | 2756 | 0.270 |
Why?
|
Bayes Theorem | 5 | 2018 | 2327 | 0.270 |
Why?
|
Quality-Adjusted Life Years | 4 | 2021 | 1723 | 0.270 |
Why?
|
Nerve Net | 5 | 2020 | 2290 | 0.260 |
Why?
|
Cerebral Hemorrhage | 3 | 2021 | 2642 | 0.260 |
Why?
|
Equipment Design | 1 | 2014 | 3501 | 0.260 |
Why?
|
Cerebral Angiography | 1 | 2011 | 1281 | 0.260 |
Why?
|
False Positive Reactions | 3 | 2018 | 957 | 0.260 |
Why?
|
Methyl Ethers | 3 | 2019 | 196 | 0.260 |
Why?
|
Cardiac Surgical Procedures | 4 | 2023 | 3621 | 0.250 |
Why?
|
Age Factors | 3 | 2020 | 18381 | 0.240 |
Why?
|
Military Personnel | 1 | 2014 | 1245 | 0.240 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2022 | 8998 | 0.240 |
Why?
|
Data Interpretation, Statistical | 4 | 2014 | 2689 | 0.240 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2014 | 1081 | 0.240 |
Why?
|
Cerebrovascular Disorders | 1 | 2011 | 1474 | 0.230 |
Why?
|
Thalamus | 2 | 2021 | 1047 | 0.230 |
Why?
|
Neurosurgical Procedures | 1 | 2015 | 2067 | 0.230 |
Why?
|
Anesthesia, General | 4 | 2019 | 1173 | 0.230 |
Why?
|
Cross-Sectional Studies | 8 | 2023 | 26065 | 0.220 |
Why?
|
Action Potentials | 2 | 2021 | 1825 | 0.220 |
Why?
|
Oxygen | 3 | 2021 | 4226 | 0.210 |
Why?
|
Pilot Projects | 4 | 2024 | 8619 | 0.210 |
Why?
|
Hospitalization | 7 | 2023 | 10708 | 0.200 |
Why?
|
Time | 2 | 2022 | 545 | 0.200 |
Why?
|
Computational Biology | 1 | 2014 | 3509 | 0.200 |
Why?
|
Disease Management | 1 | 2013 | 2506 | 0.200 |
Why?
|
Cortical Spreading Depression | 2 | 2016 | 288 | 0.200 |
Why?
|
Adolescent | 19 | 2023 | 88247 | 0.190 |
Why?
|
Mass Screening | 2 | 2014 | 5425 | 0.190 |
Why?
|
Diagnostic Techniques and Procedures | 2 | 2014 | 219 | 0.190 |
Why?
|
Hospitals, Urban | 1 | 2023 | 500 | 0.180 |
Why?
|
Quality of Life | 4 | 2018 | 13359 | 0.180 |
Why?
|
Hospital Mortality | 4 | 2023 | 5292 | 0.180 |
Why?
|
Sturge-Weber Syndrome | 1 | 2022 | 89 | 0.180 |
Why?
|
Noise | 1 | 2023 | 290 | 0.180 |
Why?
|
Problem Solving | 1 | 2023 | 444 | 0.180 |
Why?
|
Implantable Neurostimulators | 1 | 2021 | 75 | 0.180 |
Why?
|
Respiratory Rate | 1 | 2021 | 175 | 0.170 |
Why?
|
Logistic Models | 3 | 2022 | 13248 | 0.170 |
Why?
|
Artifacts | 3 | 2019 | 1910 | 0.170 |
Why?
|
Epilepsy, Rolandic | 1 | 2020 | 54 | 0.170 |
Why?
|
Hospitals | 6 | 2023 | 3879 | 0.170 |
Why?
|
Cognition | 5 | 2024 | 6988 | 0.170 |
Why?
|
Erythrocyte Indices | 1 | 2020 | 144 | 0.170 |
Why?
|
Myoclonus | 1 | 2020 | 107 | 0.170 |
Why?
|
Technology | 1 | 2022 | 293 | 0.170 |
Why?
|
Vasospasm, Intracranial | 1 | 2021 | 214 | 0.160 |
Why?
|
Length of Stay | 3 | 2022 | 6418 | 0.160 |
Why?
|
Cluster Analysis | 3 | 2020 | 2703 | 0.160 |
Why?
|
Massachusetts | 3 | 2024 | 8835 | 0.160 |
Why?
|
Infection Control Practitioners | 1 | 2018 | 12 | 0.160 |
Why?
|
HIV Infections | 2 | 2023 | 17342 | 0.150 |
Why?
|
Uncertainty | 2 | 2014 | 752 | 0.150 |
Why?
|
Electrodes | 1 | 2020 | 610 | 0.150 |
Why?
|
Benchmarking | 1 | 2024 | 1045 | 0.150 |
Why?
|
Phenytoin | 1 | 2018 | 190 | 0.150 |
Why?
|
Aspirin | 3 | 2014 | 3127 | 0.150 |
Why?
|
Cerebrovascular Circulation | 3 | 2016 | 2726 | 0.140 |
Why?
|
Brain Edema | 1 | 2022 | 604 | 0.140 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 1 | 2018 | 91 | 0.140 |
Why?
|
Delta Rhythm | 1 | 2017 | 81 | 0.140 |
Why?
|
Potassium | 1 | 2021 | 1311 | 0.140 |
Why?
|
Clinical Competence | 2 | 2024 | 4790 | 0.140 |
Why?
|
Magnetic Resonance Imaging | 10 | 2024 | 36401 | 0.130 |
Why?
|
Microvessels | 1 | 2021 | 577 | 0.130 |
Why?
|
Physical Endurance | 1 | 2018 | 366 | 0.130 |
Why?
|
False Negative Reactions | 2 | 2014 | 573 | 0.130 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3245 | 0.130 |
Why?
|
United States | 8 | 2023 | 72292 | 0.130 |
Why?
|
Risk Factors | 14 | 2024 | 74128 | 0.120 |
Why?
|
Intensive Care, Neonatal | 1 | 2017 | 199 | 0.120 |
Why?
|
Clonazepam | 1 | 2015 | 135 | 0.120 |
Why?
|
Wakefulness | 2 | 2020 | 1264 | 0.120 |
Why?
|
Longevity | 1 | 2023 | 1064 | 0.120 |
Why?
|
Electric Stimulation Therapy | 1 | 2021 | 626 | 0.120 |
Why?
|
Thoracic Surgery | 1 | 2021 | 722 | 0.120 |
Why?
|
Electrodes, Implanted | 1 | 2019 | 838 | 0.120 |
Why?
|
North America | 1 | 2018 | 1273 | 0.120 |
Why?
|
Prevalence | 2 | 2022 | 15702 | 0.120 |
Why?
|
Periventricular Nodular Heterotopia | 1 | 2015 | 53 | 0.120 |
Why?
|
Sclerosis | 1 | 2015 | 210 | 0.120 |
Why?
|
Smoking | 1 | 2011 | 9054 | 0.120 |
Why?
|
Analgesics | 1 | 2021 | 1067 | 0.120 |
Why?
|
Risk | 4 | 2017 | 9603 | 0.120 |
Why?
|
Lorazepam | 1 | 2015 | 155 | 0.120 |
Why?
|
Self Concept | 1 | 2020 | 1046 | 0.120 |
Why?
|
Nasal Obstruction | 1 | 2016 | 160 | 0.120 |
Why?
|
Withholding Treatment | 1 | 2018 | 615 | 0.120 |
Why?
|
Single-Blind Method | 2 | 2018 | 1575 | 0.110 |
Why?
|
Neurodegenerative Diseases | 1 | 2023 | 1085 | 0.110 |
Why?
|
Autonomic Nervous System | 1 | 2019 | 704 | 0.110 |
Why?
|
Databases as Topic | 1 | 2016 | 473 | 0.110 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2022 | 992 | 0.110 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2018 | 709 | 0.110 |
Why?
|
Drug Therapy, Computer-Assisted | 1 | 2015 | 197 | 0.110 |
Why?
|
Homeostasis | 2 | 2022 | 3321 | 0.110 |
Why?
|
Midazolam | 1 | 2015 | 266 | 0.110 |
Why?
|
Motor Cortex | 1 | 2021 | 1007 | 0.110 |
Why?
|
Biological Clocks | 1 | 2015 | 318 | 0.100 |
Why?
|
Transcranial Magnetic Stimulation | 3 | 2021 | 1473 | 0.100 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2023 | 2896 | 0.100 |
Why?
|
Health Services Needs and Demand | 1 | 2020 | 1400 | 0.100 |
Why?
|
Outpatients | 1 | 2021 | 1596 | 0.100 |
Why?
|
Patient Admission | 2 | 2020 | 1365 | 0.100 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 786 | 0.100 |
Why?
|
Spectrum Analysis | 1 | 2014 | 452 | 0.100 |
Why?
|
International Cooperation | 1 | 2018 | 1422 | 0.100 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1086 | 0.100 |
Why?
|
Temporal Lobe | 1 | 2019 | 1695 | 0.100 |
Why?
|
Consciousness Disorders | 1 | 2016 | 441 | 0.100 |
Why?
|
Point-of-Care Systems | 1 | 2020 | 1213 | 0.100 |
Why?
|
Comorbidity | 3 | 2022 | 10507 | 0.090 |
Why?
|
Demography | 1 | 2016 | 1643 | 0.090 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2017 | 556 | 0.090 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2019 | 2008 | 0.090 |
Why?
|
Clinical Trials as Topic | 2 | 2018 | 7995 | 0.090 |
Why?
|
Radionuclide Imaging | 1 | 2015 | 1972 | 0.090 |
Why?
|
Monitoring, Ambulatory | 1 | 2014 | 355 | 0.090 |
Why?
|
Erythrocytes | 1 | 2020 | 2410 | 0.090 |
Why?
|
Nervous System Diseases | 1 | 2021 | 1662 | 0.090 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2014 | 2746 | 0.090 |
Why?
|
Electrophysiological Phenomena | 1 | 2013 | 306 | 0.090 |
Why?
|
Microcirculation | 1 | 2015 | 1272 | 0.090 |
Why?
|
Radiopharmaceuticals | 2 | 2019 | 2650 | 0.090 |
Why?
|
Atrophy | 1 | 2015 | 1632 | 0.090 |
Why?
|
Hematocrit | 1 | 2011 | 623 | 0.090 |
Why?
|
Creutzfeldt-Jakob Syndrome | 1 | 2010 | 93 | 0.090 |
Why?
|
Antipsychotic Agents | 1 | 2023 | 3067 | 0.090 |
Why?
|
Myocardial Infarction | 1 | 2011 | 11458 | 0.080 |
Why?
|
Magnetic Resonance Angiography | 1 | 2016 | 1431 | 0.080 |
Why?
|
Positron-Emission Tomography | 3 | 2019 | 6483 | 0.080 |
Why?
|
Alpha Rhythm | 2 | 2024 | 111 | 0.080 |
Why?
|
Sleep, REM | 3 | 2024 | 595 | 0.080 |
Why?
|
Calcium | 1 | 2022 | 5717 | 0.080 |
Why?
|
Diagnosis, Differential | 3 | 2021 | 12966 | 0.080 |
Why?
|
Likelihood Functions | 1 | 2012 | 991 | 0.080 |
Why?
|
Autopsy | 1 | 2013 | 1008 | 0.080 |
Why?
|
Neural Pathways | 3 | 2021 | 3056 | 0.080 |
Why?
|
Practice Guidelines as Topic | 3 | 2016 | 7390 | 0.080 |
Why?
|
Scalp | 2 | 2022 | 389 | 0.080 |
Why?
|
Case-Control Studies | 3 | 2022 | 22153 | 0.080 |
Why?
|
Posture | 1 | 2012 | 956 | 0.080 |
Why?
|
Boston | 2 | 2020 | 9313 | 0.080 |
Why?
|
Glasgow Coma Scale | 2 | 2022 | 579 | 0.080 |
Why?
|
Least-Squares Analysis | 2 | 2013 | 368 | 0.070 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2011 | 277 | 0.070 |
Why?
|
Hydrocephalus | 1 | 2014 | 764 | 0.070 |
Why?
|
Databases, Genetic | 1 | 2014 | 1742 | 0.070 |
Why?
|
Immunologic Factors | 1 | 2017 | 1589 | 0.070 |
Why?
|
Hippocampus | 2 | 2022 | 3762 | 0.070 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39062 | 0.070 |
Why?
|
Quality Improvement | 1 | 2022 | 3801 | 0.070 |
Why?
|
Terminology as Topic | 1 | 2014 | 1528 | 0.070 |
Why?
|
Glucose | 1 | 2019 | 4345 | 0.070 |
Why?
|
Unconsciousness | 2 | 2022 | 249 | 0.070 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2016 | 2789 | 0.070 |
Why?
|
Adenosine Triphosphate | 1 | 2013 | 1988 | 0.070 |
Why?
|
Consensus | 1 | 2016 | 3117 | 0.070 |
Why?
|
Models, Statistical | 2 | 2018 | 5074 | 0.070 |
Why?
|
Recurrence | 1 | 2018 | 8426 | 0.060 |
Why?
|
Acute Disease | 2 | 2019 | 7236 | 0.060 |
Why?
|
Quality Assurance, Health Care | 1 | 2016 | 2164 | 0.060 |
Why?
|
Sepsis | 1 | 2020 | 2585 | 0.060 |
Why?
|
Chronic Disease | 1 | 2020 | 9310 | 0.060 |
Why?
|
Syndrome | 1 | 2011 | 3268 | 0.060 |
Why?
|
Primary Prevention | 1 | 2012 | 1185 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2270 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9277 | 0.060 |
Why?
|
Cardiopulmonary Bypass | 2 | 2020 | 1092 | 0.060 |
Why?
|
Incidence | 1 | 2022 | 21339 | 0.060 |
Why?
|
Child | 8 | 2022 | 80089 | 0.060 |
Why?
|
Postoperative Complications | 3 | 2023 | 15609 | 0.050 |
Why?
|
Catheterization, Central Venous | 1 | 2008 | 526 | 0.050 |
Why?
|
Residence Characteristics | 1 | 2013 | 2092 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3088 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3209 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10754 | 0.050 |
Why?
|
Otolithic Membrane | 1 | 2002 | 38 | 0.050 |
Why?
|
Sodium-Calcium Exchanger | 1 | 2022 | 90 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5334 | 0.050 |
Why?
|
Epilepsia Partialis Continua | 1 | 2021 | 18 | 0.050 |
Why?
|
Psychometrics | 1 | 2011 | 3062 | 0.050 |
Why?
|
Bacteremia | 1 | 2008 | 977 | 0.050 |
Why?
|
Acceleration | 1 | 2002 | 189 | 0.050 |
Why?
|
Competency-Based Education | 1 | 2022 | 222 | 0.050 |
Why?
|
Semicircular Canals | 1 | 2002 | 203 | 0.040 |
Why?
|
Infant, Newborn | 2 | 2019 | 26183 | 0.040 |
Why?
|
Vestibule, Labyrinth | 1 | 2002 | 234 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2018 | 5838 | 0.040 |
Why?
|
Foramen Ovale | 1 | 2019 | 17 | 0.040 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2021 | 281 | 0.040 |
Why?
|
Communication | 1 | 2014 | 3851 | 0.040 |
Why?
|
Data Mining | 1 | 2024 | 551 | 0.040 |
Why?
|
Recovery of Function | 2 | 2020 | 2977 | 0.040 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2020 | 137 | 0.040 |
Why?
|
Research Report | 1 | 2022 | 367 | 0.040 |
Why?
|
Education, Medical | 1 | 2011 | 1725 | 0.040 |
Why?
|
Calcium Channels | 1 | 2022 | 620 | 0.040 |
Why?
|
Child, Preschool | 5 | 2021 | 42193 | 0.040 |
Why?
|
Hypertension | 1 | 2018 | 8532 | 0.040 |
Why?
|
Classification | 1 | 2018 | 127 | 0.040 |
Why?
|
Hospitals, Private | 1 | 2018 | 63 | 0.040 |
Why?
|
Posterior Leukoencephalopathy Syndrome | 1 | 2019 | 49 | 0.040 |
Why?
|
Solubility | 1 | 2020 | 1089 | 0.040 |
Why?
|
Coronavirus | 1 | 2020 | 156 | 0.040 |
Why?
|
Insurance Claim Reporting | 1 | 2018 | 165 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2024 | 10203 | 0.040 |
Why?
|
Population Surveillance | 1 | 2008 | 2597 | 0.040 |
Why?
|
Academies and Institutes | 1 | 2020 | 318 | 0.040 |
Why?
|
Frail Elderly | 1 | 2023 | 765 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 2019 | 1624 | 0.040 |
Why?
|
Video Recording | 1 | 2022 | 965 | 0.030 |
Why?
|
Reference Standards | 1 | 2019 | 1003 | 0.030 |
Why?
|
Switzerland | 1 | 2016 | 318 | 0.030 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 2017 | 133 | 0.030 |
Why?
|
Review Literature as Topic | 1 | 2018 | 347 | 0.030 |
Why?
|
Area Under Curve | 1 | 2019 | 1635 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2018 | 5239 | 0.030 |
Why?
|
Thrombectomy | 1 | 2020 | 702 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2015 | 6223 | 0.030 |
Why?
|
Spin Labels | 1 | 2016 | 337 | 0.030 |
Why?
|
Models, Biological | 2 | 2018 | 9461 | 0.030 |
Why?
|
Longitudinal Studies | 3 | 2016 | 14599 | 0.030 |
Why?
|
Pyrazines | 1 | 2020 | 1202 | 0.030 |
Why?
|
Evoked Potentials | 1 | 2020 | 1047 | 0.030 |
Why?
|
Diffusion Tensor Imaging | 1 | 2024 | 2400 | 0.030 |
Why?
|
Motor Activity | 1 | 2024 | 2714 | 0.030 |
Why?
|
Observation | 1 | 2015 | 310 | 0.030 |
Why?
|
Hypothermia | 1 | 2015 | 188 | 0.030 |
Why?
|
Poverty Areas | 1 | 2014 | 263 | 0.030 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2018 | 619 | 0.030 |
Why?
|
Intubation, Intratracheal | 1 | 2020 | 1331 | 0.030 |
Why?
|
Supine Position | 1 | 2012 | 205 | 0.030 |
Why?
|
Electrooculography | 1 | 2012 | 113 | 0.020 |
Why?
|
Pattern Recognition, Automated | 1 | 2018 | 994 | 0.020 |
Why?
|
Postoperative Period | 1 | 2017 | 1812 | 0.020 |
Why?
|
Medical History Taking | 1 | 2016 | 773 | 0.020 |
Why?
|
Decision Support Systems, Clinical | 1 | 2021 | 1171 | 0.020 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2012 | 119 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2018 | 2079 | 0.020 |
Why?
|
Behavior | 1 | 2014 | 540 | 0.020 |
Why?
|
Thrombolytic Therapy | 1 | 2020 | 2055 | 0.020 |
Why?
|
Postmortem Changes | 1 | 2010 | 119 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2851 | 0.020 |
Why?
|
Self Care | 1 | 2016 | 796 | 0.020 |
Why?
|
Pandemics | 2 | 2020 | 8652 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2017 | 1835 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2014 | 1380 | 0.020 |
Why?
|
Regression Analysis | 1 | 2018 | 6339 | 0.020 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2015 | 1140 | 0.020 |
Why?
|
Internationality | 1 | 2014 | 1000 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2013 | 2214 | 0.020 |
Why?
|
Missouri | 1 | 2008 | 115 | 0.020 |
Why?
|
Functional Laterality | 1 | 2015 | 2256 | 0.020 |
Why?
|
Neurons | 2 | 2024 | 9436 | 0.020 |
Why?
|
Hospitals, University | 1 | 2008 | 565 | 0.020 |
Why?
|
Odds Ratio | 1 | 2018 | 9644 | 0.020 |
Why?
|
Culture Media | 1 | 2008 | 895 | 0.020 |
Why?
|
Patient Compliance | 1 | 2016 | 2688 | 0.020 |
Why?
|
Blood | 1 | 2008 | 596 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12448 | 0.020 |
Why?
|
Neoplasms | 1 | 2014 | 22131 | 0.020 |
Why?
|
Photic Stimulation | 1 | 2012 | 1987 | 0.020 |
Why?
|
Survival Analysis | 1 | 2017 | 10072 | 0.010 |
Why?
|
Medicare | 1 | 2022 | 6774 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2018 | 12333 | 0.010 |
Why?
|
Vestibular Nuclei | 1 | 2002 | 22 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2013 | 8165 | 0.010 |
Why?
|
Gravitation | 1 | 2002 | 82 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2013 | 2222 | 0.010 |
Why?
|
Vestibular Nerve | 1 | 2002 | 101 | 0.010 |
Why?
|
Reflex, Vestibulo-Ocular | 1 | 2002 | 86 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2014 | 3599 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7873 | 0.010 |
Why?
|
Haplorhini | 1 | 2002 | 525 | 0.010 |
Why?
|
Neurobiology | 1 | 2002 | 137 | 0.010 |
Why?
|
Disease Progression | 1 | 2017 | 13495 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2022 | 20556 | 0.010 |
Why?
|
Rats | 1 | 2013 | 23716 | 0.010 |
Why?
|
Phenotype | 1 | 2012 | 16572 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18220 | 0.010 |
Why?
|
Infant | 1 | 2015 | 36157 | 0.010 |
Why?
|
Animals | 2 | 2013 | 168202 | 0.000 |
Why?
|